Sign Up!
Login
Wow, tough one. Child, 9, rare fatal musculature disease, experimental drug vastly improves his life. But inconsistent efficacy puts the FDA in a rough spot, they have to decide to approve/disapprove. Disapprove and this boy loses his medicine.
Comments: Add Comment